Evaluation du système noradrénergique dans l'altération de la perception douloureuse chez le patient Parkinsonien

Trial Profile

Evaluation du système noradrénergique dans l'altération de la perception douloureuse chez le patient Parkinsonien

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Pain; Parkinsonian disorders
  • Focus Pharmacodynamics
  • Acronyms DOULOX
  • Most Recent Events

    • 01 Oct 2016 Status changed from recruiting to completed.
    • 10 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top